Literature DB >> 9727046

Identity of the beta-globin locus control region binding protein HS2NF5 as the mammalian homolog of the notch-regulated transcription factor suppressor of hairless.

L T Lam1, E H Bresnick.   

Abstract

Previously, we characterized a DNA-binding protein, HS2NF5, that bound tightly to a conserved region within hypersensitive site 2 (HS2) of the human beta-globin locus control region (LCR) (Lam, L. T. , and Bresnick, E. H. (1996) J. Biol. Chem. 271, 32421-32429). The beta-globin LCR controls the chromatin structure, transcription, and replication of the beta-globin genes. We have now purified HS2NF5 to near-homogeneity from fetal bovine thymus. Two polypeptides of 56 and 61 kDa copurified with the DNA binding activity. The two proteins bound to the LCR recognition site with an affinity (3.1 nM) and specificity similar to mouse erythroleukemia cell HS2NF5. The amino acid sequences of tryptic peptides of purified HS2NF5 revealed it to be identical to the murine homolog of the suppressor of hairless transcription factor, also known as recombination signal binding protein Jkappa or C promoter binding factor 1 (CBF1). The CBF1 site within HS2 resides near sites for hematopoietic regulators such as GATA-1, NF-E2, and TAL1. An additional conserved, high affinity CBF1 site was localized within HS4 of the LCR. As CBF1 is a downstream target of the Notch signaling pathway, we propose that Notch may modulate LCR activity during hematopoiesis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9727046     DOI: 10.1074/jbc.273.37.24223

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  Direct induction of T lymphocyte-specific gene expression by the mammalian Notch signaling pathway.

Authors:  Boris Reizis; Philip Leder
Journal:  Genes Dev       Date:  2002-02-01       Impact factor: 11.361

2.  Gamma -secretase inhibitors repress thymocyte development.

Authors:  B K Hadland; N R Manley; D Su ; G D Longmore; C L Moore; M S Wolfe; E H Schroeter; R Kopan
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-19       Impact factor: 11.205

3.  Requirements for utilization of CREB binding protein by hypersensitive site two of the beta-globin locus control region.

Authors:  Kirby D Johnson; Jason E Norton; Emery H Bresnick
Journal:  Nucleic Acids Res       Date:  2002-04-01       Impact factor: 16.971

4.  Molecular determinants of NOTCH4 transcription in vascular endothelium.

Authors:  Jing Wu; Fumiko Iwata; Jeffrey A Grass; Cameron S Osborne; Laura Elnitski; Peter Fraser; Osamu Ohneda; Masayuki Yamamoto; Emery H Bresnick
Journal:  Mol Cell Biol       Date:  2005-02       Impact factor: 4.272

5.  Induction of cyclin D1 transcription and CDK2 activity by Notch(ic): implication for cell cycle disruption in transformation by Notch(ic).

Authors:  C Ronchini; A J Capobianco
Journal:  Mol Cell Biol       Date:  2001-09       Impact factor: 4.272

6.  Notch4 Signaling Induces a Mesenchymal-Epithelial-like Transition in Melanoma Cells to Suppress Malignant Behaviors.

Authors:  Ehsan Bonyadi Rad; Heinz Hammerlindl; Christian Wels; Ulrich Popper; Dinoop Ravindran Menon; Heimo Breiteneder; Melitta Kitzwoegerer; Christine Hafner; Meenhard Herlyn; Helmut Bergler; Helmut Schaider
Journal:  Cancer Res       Date:  2016-01-22       Impact factor: 12.701

7.  Fission yeast CSL proteins function as transcription factors.

Authors:  Martina Oravcová; Mikoláš Teska; František Půta; Petr Folk; Martin Převorovský
Journal:  PLoS One       Date:  2013-03-15       Impact factor: 3.240

8.  Computational models of the Notch network elucidate mechanisms of context-dependent signaling.

Authors:  Smita Agrawal; Colin Archer; David V Schaffer
Journal:  PLoS Comput Biol       Date:  2009-05-22       Impact factor: 4.475

9.  BRCA1 is a key regulator of breast differentiation through activation of Notch signalling with implications for anti-endocrine treatment of breast cancers.

Authors:  Niamh E Buckley; Caoimhe B Nic An tSaoir; Jaine K Blayney; Lisa C Oram; Nyree T Crawford; Zenobia C D'Costa; Jennifer E Quinn; Richard D Kennedy; D Paul Harkin; Paul B Mullan
Journal:  Nucleic Acids Res       Date:  2013-07-17       Impact factor: 16.971

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.